Benitec Biopharma Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.73 | -$0.73 | -$0.73 |
| Q2 2024 | 1 | -$0.79 | -$0.79 | -$0.79 |
| Q3 2024 | 1 | -$1.98 | -$0.91 | -$1.45 |
| Q1 2025 | 1 | -$2.06 | -$0.90 | -$1.48 |
| Q2 2025 | 1 | -$1.54 | -$1.54 | -$1.54 |
| Q3 2025 | 1 | -$1.03 | -$1.03 | -$1.03 |
| Q4 2025 | 1 | -$1.04 | -$1.04 | -$1.04 |
| Q1 2026 | 1 | -$1.04 | -$1.04 | -$1.04 |
| Q2 2026 | 1 | -$0.94 | -$0.94 | -$0.94 |
| Q3 2026 | 1 | -$0.91 | -$0.91 | -$0.91 |
| Q4 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q1 2027 | 1 | -$0.85 | -$0.85 | -$0.85 |
| Q2 2027 | 1 | -$0.82 | -$0.82 | -$0.82 |
Benitec Biopharma Inc. Earnings Date And Information
Benitec Biopharma Inc. last posted its earnings results on Thursday, September 26th, 2024. The company reported $-1.32 earnings per share for the quarter, missing analysts' consensus estimates of $-0.49 by $0.83. The company had revenue of 0 for the quarter and had revenue of 216,000 for the year. Benitec Biopharma Inc. has generated $-5 earnings per share over the last year ($-5.36 diluted earnings per share) and currently has a price-to-earnings ratio of -5.35. Benitec Biopharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 10th, 2025 based on prior year's report dates.
Benitec Biopharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q1 2025 | -$0.48 | $0 | $0 | ||
| 09/26/2024 | Q4 2024 | -$0.49 | -$1.16 | -0.67 | $0 | $0 |
| 05/13/2024 | Q3 2024 | -$0.78 | -$1.64 | -0.86 | $6,000 | |
| 02/13/2024 | Q2 2024 | -$0.39 | -$2.64 | -2.25 | $0 | |
| 11/13/2023 | Q1 2024 | -$0.51 | -$2.76 | -2.25 | $0 | |
| 09/21/2023 | Q4 2023 | -$3.23 | -$2.83 | 0.4 | $7,000 | |
| 05/15/2023 | Q3 2023 | -$0.20 | -$2.71 | -2.51 | $54,000 | |
| 02/13/2023 | Q2 2023 | -$0.11 | -$3.22 | -3.11 | $14,000 | |
| 11/10/2022 | Q1 2023 | -$2.04 | -$8.78 | -6.74 | $14,681 | $472,000 |
| 09/02/2022 | Q4 2022 | -$4.76 | -$10.54 | -5.78 | $0 | |
| 05/16/2022 | Q3 2022 | -$7.48 | -$6.43 | 1.05 | $48,000 | |
| 02/14/2022 | Q2 2022 | -$10.03 | $25,000 | |||
| 11/15/2021 | Q1 2022 | -$10.50 | $0 | |||
| 09/20/2021 | Q4 2021 | -$9.64 | $6,664 | $2,000 | ||
| 05/12/2021 | Q3 2021 | -$14.00 | $1,000 | |||
| 02/09/2021 | Q2 2021 | -$0.75 | -$12.86 | -12.11 | $1,000 | |
| 11/13/2020 | Q1 2021 | -$0.92 | -$41.69 | -40.77 | $90,669 | $55,000 |
| 09/23/2020 | Q4 2020 | -$0.01 | -$45.40 | -45.39 | $183,584 | $-40,000 |
| 03/30/2020 | Q3 2020 | -$33.37 | $28,000 | |||
| 12/30/2019 | Q2 2020 | -$34.05 | $77,000 |
Benitec Biopharma Inc. Earnings: Frequently Asked Questions
-
When is Benitec Biopharma Inc.'s earnings date?
Benitec Biopharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 10th, 2025 based off last year's report dates.
-
How can I listen to Benitec Biopharma Inc.'s earnings conference call?
The conference call for Benitec Biopharma Inc.'s latest earnings report can be listened to online.
-
How can I read Benitec Biopharma Inc.'s conference call transcript?
The conference call transcript for Benitec Biopharma Inc.'s latest earnings report can be read online.
-
How much revenue does Benitec Biopharma Inc. generate each year?
Benitec Biopharma Inc. (:BNTC) has a recorded annual revenue of $216,000.
-
How much profit does Benitec Biopharma Inc. generate each year?
Benitec Biopharma Inc. (:BNTC) has a recorded net income of $216,000. Benitec Biopharma Inc. has generated $-5.36 earnings per share over the last four quarters.
-
What is Benitec Biopharma Inc.'s price-to-earnings ratio?
Benitec Biopharma Inc. (:BNTC) has a price-to-earnings ratio of -5.35 and price/earnings-to-growth ratio is -0.39.
